On Monday, ATAI Life Sciences N.V (NASDAQ: ATAI) was -5.33% drop from the session before settling in for the closing price of $1.50. A 52-week range for ATAI has been $1.03 – $2.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -16.02%. When this article was written, the company’s average yearly earnings per share was at -217.14%. With a float of $117.06 million, this company’s outstanding shares have now reached $167.82 million.
The extent of productivity of a business whose workforce counts for 83 workers is very important to gauge. In terms of profitability, gross margin is 19.64%, operating margin of -31987.01%, and the pretax margin is -38614.5%.
ATAI Life Sciences N.V (ATAI) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ATAI Life Sciences N.V stocks. The insider ownership of ATAI Life Sciences N.V is 30.24%, while institutional ownership is 7.12%. The most recent insider transaction that took place on Sep 26 ’24, was worth 16,093,000. In this transaction 10% Owner of this company sold 2,660,000 shares at a rate of $6.05, taking the stock ownership to the 6,905,774 shares. Before that another transaction happened on May 16 ’24, when Company’s insider sold 151,303 for $1.92, making the entire transaction worth $290,502. This insider now owns 328,697 shares in total.
ATAI Life Sciences N.V (ATAI) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -217.14% per share during the next fiscal year.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
You can see what ATAI Life Sciences N.V (ATAI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 722.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
The latest stats from [ATAI Life Sciences N.V, ATAI] show that its last 5-days average volume of 2.4 million was inferior to 2.81 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 43.53%. Additionally, its Average True Range was 0.15.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 42.39%, which indicates a significant increase from 35.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.24% in the past 14 days, which was higher than the 82.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4468, while its 200-day Moving Average is $1.4952. Now, the first resistance to watch is $1.5017. This is followed by the second major resistance level at $1.5833. The third major resistance level sits at $1.6467. If the price goes on to break the first support level at $1.3567, it is likely to go to the next support level at $1.2933. Assuming the price breaks the second support level, the third support level stands at $1.2117.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
There are 167,802K outstanding shares of the company, which has a market capitalization of 238.28 million. As of now, sales total 310 K while income totals -40,220 K. Its latest quarter income was 40 K while its last quarter net income were -26,290 K.
